Now livetag icon
Who's really winning the World Cup economy? The data is in!Get the snapshotbanner icon
Biohaven

May 2026

Biohaven Market Share Analysis for May 2026

DescriptionHarnessing the boundless potential of scientific innovation to transform the treatment of neurological and neuropsychiatric diseases. Summarized from the website
Year Founded2022
Employees201 - 500
Annual Revenue--
biohaven.com
Biohaven
Biohaven (including company regionals)
  • biohaven.com
    biohaven.com
See more website traffic and engagement information

Total visits to Biohaven's top domains

Understand Biohaven market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Biohaven's top domains

Analyze Biohaven engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Biohaven's top domains

See how Biohaven keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.


Biohaven top competitors by domain

Top similar sites in May 2026, ranked by their affinity

Benchmark Your Digital Performance

Identify high-value opportunities, track your performance, and win your market.


Top technologies used by Biohaven

These are the website technologies, by industry, used by Biohaven top domains

Widget (5)

Yoast SEO

Yoast SEO

Content Management System (3)

WordPress

WordPress

Marketing (3)

Google Marketing Platform

Google Marketing Platform

Conversion & Analytics (2)

Google Analytics

Google Analytics

More Technologies

9

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Biohaven

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBiohaven Ltd. is developing taldefgrobep alfa.* Biohaven has completed enrollment for its Phase 2 proof of concept trial evaluating obesity drug candidate taldefgrobep alfa.
NewsBiohaven Ltd. attended event 2025 European Society for Medical Oncology (ESMO) Immuno-Oncology Congress on Dec 11th '25.LONDON and NEW HAVEN, Conn., Dec. 11, 2025 /PRNewswire/ - Biohaven Ltd. (NYSE: BHVN) announced today that it presented clinical safety and efficacy data for BHV-1510 at the 2025 European Society for Medical Oncology (ESMO) Immuno-Oncology Congress, taking place from December 10-12, 2025, in London, United Kingdom.
NewsBiohaven Ltd. was planning to receive financing of $175M in public offering on Nov 13th '25.Biohaven announces pricing of $175 million public offering of common shares.

See all Biohaven signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.